ClinicalTrials.gov
ClinicalTrials.gov Menu

Influence of Respiratory Muscle Training in Elderly Hypertensive Women With Respiratory Muscle Weakness

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01743183
Recruitment Status : Completed
First Posted : December 6, 2012
Last Update Posted : December 6, 2012
Sponsor:
Collaborator:
Foundation for research support from the state of Rio Grande do Norte (FAPERN)
Information provided by (Responsible Party):
Patra-cia Angelica de Miranda Silva Nogueira, Universidade Federal do Rio Grande do Norte

Brief Summary:
This study aims to evaluate pulmonary function and respiratory muscle strength in a group of elderly women with hypertension before and after a respiratory muscle training.

Condition or disease Intervention/treatment Phase
Hypertension Device: Threshold Not Applicable

Detailed Description:
It is a respiratory muscle training using the Threshold for 5 weeks, with a load of 30% of maximal inspiratory pressure obtained in manometer for 30 minutes daily. Furthermore, the assessment includes: test 6-minute walk, the quality of life questionnaire, MINICHAL, the IPAQ short version, manometer and spirometry.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 4 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Influence of Respiratory Muscle Training in Elderly Hypertensive Women With Respiratory Muscle Weakness
Study Start Date : September 2012
Actual Primary Completion Date : October 2012
Actual Study Completion Date : November 2012

Arm Intervention/treatment
Experimental: threshold
Held inspiratory muscle strengthening for 5 weeks with Threshold, charging 30% of maximal inspiratory pressure, 7 days a week, one supervised and unsupervised 6.
Device: Threshold
The load adjustment was done weekly by a single examiner.



Primary Outcome Measures :
  1. manovacuometry [ Time Frame: 6 weeks ]
    Evaluates indirectly respiratory muscle strength.


Secondary Outcome Measures :
  1. spirometry
    Assesses lung function


Other Outcome Measures:
  1. quality of life
    Assesses the influence of hypertension on the quality of life of target

  2. functional capacity
    assesses the cardiopulmonary capacity at sub-maximal

  3. IPAQ
    assesses the level of physical activity



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   60 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • diagnosis of hypertension controlled by antihypertensive;
  • aged between 60 and 80 years;
  • absence of dementia or cognitive impairments that limit tests;
  • absence of recent myocardial infarction;
  • absence of musculoskeletal limitations that limit tests;
  • availability of time on training days.

Exclusion Criteria:

  • clinical instability;
  • inability to perform any test.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01743183


Locations
Brazil
Universidade Federal do Rio Grande do Norte
Natal, Rio Grande do Norte, Brazil
Sponsors and Collaborators
Universidade Federal do Rio Grande do Norte
Foundation for research support from the state of Rio Grande do Norte (FAPERN)
Investigators
Principal Investigator: Patrícia Nogueira Universidade Federal do Rio Grande do Norte

Responsible Party: Patra-cia Angelica de Miranda Silva Nogueira, Patrícia Angélica de Miranda Silva Nogueira, Universidade Federal do Rio Grande do Norte
ClinicalTrials.gov Identifier: NCT01743183     History of Changes
Other Study ID Numbers: 05135912.8.0000.5537
First Posted: December 6, 2012    Key Record Dates
Last Update Posted: December 6, 2012
Last Verified: December 2012

Keywords provided by Patra-cia Angelica de Miranda Silva Nogueira, Universidade Federal do Rio Grande do Norte:
hypertension

Additional relevant MeSH terms:
Hypertension
Muscle Weakness
Paresis
Vascular Diseases
Cardiovascular Diseases
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Manifestations
Neurologic Manifestations
Nervous System Diseases
Pathologic Processes
Signs and Symptoms